NCT03639493 - Bioequivalence Study of CJ-30060 in Healthy Male Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 6, 2018

Primary Completion Date

May 4, 2018

Study Completion Date

May 17, 2018

Conditions

Healthy Male Subjects

Interventions

DRUG

Exforge® tab 10/160mg, Crestor® tab 20mg

Co-administration of Amlodipine 10mg/ Valsartan 160mg(combination drug) and Rosuvastatin 20mg

DRUG

CJ-30060 10/160/20mg

Fixed-dose combination drug containing Amlodipine 10mg and Valsartan 160mg and Rosuvastatin 20mg

Trial Locations (1)

Korea University Anam Hospital, Seoul